−12 IDR
16.51 B IDR
175.13 B IDR
About MULTIMEDIKA INTERNASIONAL TBK
Sector
Industry
CEO
Mengky Mangarek
Website
Headquarters
Jakarta
Founded
2020
ISIN
ID1000178700
FIGI
BBG01BHV7DB9
PT Multi Medika Internasional Tbk engages in the business of distributing healthcare products. It operates through the following product segments: Masker, Face Shield, Aromatherapy Patch, Tumbler, Merchandise and RTD Coffee. The company was founded by Mengky Mangarek and Eveline Natalia Susanto on September 28, 2020 and is headquartered in Jakarta, Indonesia.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MMIX is 97 IDR — it has increased by 7.78% in the past 24 hours. Watch MULTIMEDIKA INTERNASIONAL TBK stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on IDX exchange MULTIMEDIKA INTERNASIONAL TBK stocks are traded under the ticker MMIX.
MMIX stock has risen by 12.79% compared to the previous week, the month change is a 10.23% rise, over the last year MULTIMEDIKA INTERNASIONAL TBK has showed a −40.12% decrease.
MMIX reached its all-time high on Mar 13, 2023 with the price of 710 IDR, and its all-time low was 50 IDR and was reached on Mar 26, 2024. View more price dynamics on MMIX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MMIX stock is 18.39% volatile and has beta coefficient of 0.06. Track MULTIMEDIKA INTERNASIONAL TBK stock price on the chart and check out the list of the most volatile stocks — is MULTIMEDIKA INTERNASIONAL TBK there?
Yes, you can track MULTIMEDIKA INTERNASIONAL TBK financials in yearly and quarterly reports right on TradingView.
MMIX net income for the last quarter is −14.04 B IDR, while the quarter before that showed −2.82 B IDR of net income which accounts for −398.45% change. Track more MULTIMEDIKA INTERNASIONAL TBK financial stats to get the full picture.
No, MMIX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 27, 2024, the company has 112.00 employees. See our rating of the largest employees — is MULTIMEDIKA INTERNASIONAL TBK on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MULTIMEDIKA INTERNASIONAL TBK EBITDA is −1.46 B IDR, and current EBITDA margin is 17.55%. See more stats in MULTIMEDIKA INTERNASIONAL TBK financial statements.
Like other stocks, MMIX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MULTIMEDIKA INTERNASIONAL TBK stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MULTIMEDIKA INTERNASIONAL TBK technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MULTIMEDIKA INTERNASIONAL TBK stock shows the neutral signal. See more of MULTIMEDIKA INTERNASIONAL TBK technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.